Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 13 of 13 for “"GARFTase"”.

  1. Synthesis of novel 5-substituted pyrrolo[2,3-d]pyrimidine antifolates as selective and potent anti-tumor agents

    … and/or PCFT and over RFC targets inhibition of GARFTase dependent salvage pathway for purine biosynthesis inside the tumor. Based on this premise, five 5-substituted pyrrolo[2,3-<em>d</em>]pyrimidines have been designed, synthesized and characterized. Among them four are novel compounds and one …

    duquesne Repository record for Synthesis of novel 5-substituted pyrrolo[2,3-d]pyrimidine antifolates as selective and potent anti-tumor agents (opens in a new tab)

  2. Discovery of Pyrimidine-based Heterocycles as Single Agents With Combination Chemotherapy Potential And As Inhibitors Of Purine Nucleotide Biosynthesis For The Treatment of Cancer

    … bridge substitution<strong> </strong>as GARFTase inhibitors.<strong></strong></p> <p>The work in this dissertation is centered on identifying structural features that are necessary for inhibition of tubulin polymerization as well as for inhibition of one or more of the receptor tyrosine …

    duquesne Repository record for Discovery of Pyrimidine-based Heterocycles as Single Agents With Combination Chemotherapy Potential And As Inhibitors Of Purine Nucleotide Biosynthesis For The Treatment of Cancer (opens in a new tab)

  3. Classical Antifolates: Synthesis of 5-Substituted, 6-Substituted and 7-Substituted Pyrrolo[2,3-d]Pyrimidines as Targeted Anticancer Therapies

    … or/and PCFT and tumor targeted antifolates with GARFTase or multiple folate metabolizing enzyme inhibition. The design strategies employed include: variation of the side chain substitution position (5-, 6- and 7-substituted); variation of the side chain length (n=1-6); isosteric replacement of …

    duquesne Repository record for Classical Antifolates: Synthesis of 5-Substituted, 6-Substituted and 7-Substituted Pyrrolo[2,3-d]Pyrimidines as Targeted Anticancer Therapies (opens in a new tab)

  4. Therapeutic Dual-Targeting Of Cytosolic And Mitochondrial One-Carbon Metabolism

    … glycinamide ribonucleotide formyltransferase (GARFTase) and/or 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase (AICARFTase). By depleting SHMT2-derived formate, these compounds potentiated their own inhibition of the downstream formate-dependent GARFTase and AICARFTase. We …

    wayne-thes Repository record for Therapeutic Dual-Targeting Of Cytosolic And Mitochondrial One-Carbon Metabolism (opens in a new tab)

  5. Synthesis of Bicyclic Thieno[2,3-d]Pyrimidines, Tricyclic Thieno[2,3-d]Pyrimidines and Thieno[3,2-d]Pyrimidines as Classical and Nonclassical Antifolates

    … glycinamide ribonucleotide formyltransferase (GARFTase) are important folate dependent enzymes that are targets for cancer chemotherapy and the treatment of infectious diseases. As a part of this study, thirty-five novel compounds were designed and synthesized on the basis of existing …

    duquesne Repository record for Synthesis of Bicyclic Thieno[2,3-d]Pyrimidines, Tricyclic Thieno[2,3-d]Pyrimidines and Thieno[3,2-d]Pyrimidines as Classical and Nonclassical Antifolates (opens in a new tab)

  6. TARGETING CANCER- ONE CARBON AT A TIME: DESIGN AND SYNTHESIS OF PYRIMIDINE BASED HETEROCYCLES AS POTENTIAL CANCER CHEMOTHERAPEUTICS

    … (MTX; DHFR inhibitor), pemetrexed (PMX; TS and GARFTase inhibitor), pralatrexate (PTX; DHFR inhibitor), and raltitrexed (RTX; TS inhibitor), are limited by two major disadvantages: (1) dose-limiting toxicities due to ubiquitous transport via the reduced folate carrier (RFC) and (2) …

    duquesne Repository record for TARGETING CANCER- ONE CARBON AT A TIME: DESIGN AND SYNTHESIS OF PYRIMIDINE BASED HETEROCYCLES AS POTENTIAL CANCER CHEMOTHERAPEUTICS (opens in a new tab)

  7. Targeting Metabolic Vulnerabilities In Epithelial Ovarian Cancer Via Folate Transporters

    … glycinamide ribonucleotide formyltransferase (GARFTase) was confirmed by metabolite rescue, metabolomics and enzyme assays. X-ray crystallographic structures were obtained with compounds AGF102, AGF103 and AGF131 and human GARFTase. Our studies identify first-in-class C1 inhibitors with …

    wayne-thes Repository record for Targeting Metabolic Vulnerabilities In Epithelial Ovarian Cancer Via Folate Transporters (opens in a new tab)

  8. Synthesis of furo[2,3-d]pyrimidines, thieno[2,3- d]pyrimidines, pyrrolo[2,3-d]pyrimidines as classical and nonclassical antifolates, receptor tyrosine kinase (RTK) inhibitors and antimitotic agents

    … glycinamide ribonucleotide formyltransferase (GARFTase) are important folate dependent enzymes that are targets for cancer chemotherapy and the treatment of infectious diseases. Classical antifolates, in most cases, are substrates for folypoly - γ - glutamate synthase (FPGS) and rely on folate …

    duquesne Repository record for Synthesis of furo[2,3-d]pyrimidines, thieno[2,3- d]pyrimidines, pyrrolo[2,3-d]pyrimidines as classical and nonclassical antifolates, receptor tyrosine kinase (RTK) inhibitors and antimitotic agents (opens in a new tab)

  9. DESIGN AND SYNTHESIS OF FUSED PYRIMIDINES AS MULTI-TARGETED POTENTIAL ANTICANCER AGENTS

    … ribonucleotide (GAR) formyltransferase (GARFTase) and 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase (AICARFTase) inhibitors b) single agents with combination chemotherapy potential, with dual antiangiogenic and anti-tubulin effects. One-carbon metabolism inhibitors have …

    duquesne Repository record for DESIGN AND SYNTHESIS OF FUSED PYRIMIDINES AS MULTI-TARGETED POTENTIAL ANTICANCER AGENTS (opens in a new tab)

  10. Design and Synthesis of Pyrimidine Based Heterocycles as Potential Anti-cancer Agents with Combination Chemotherapeutic Potential or Targeted One Carbon Metabolism Inhibition and Anti-opportunistic Agents

    … as targeted one-carbon metabolism enzymes (GARFTase/AICARFTase and/or SHMT2) inhibitors circumventing both dose-limiting toxicity and tumor resistance associated with most prescribed antitumor agents like pemetrexed. PCP is a host species-specific infection. Current therapies such as …

    duquesne Repository record for Design and Synthesis of Pyrimidine Based Heterocycles as Potential Anti-cancer Agents with Combination Chemotherapeutic Potential or Targeted One Carbon Metabolism Inhibition and Anti-opportunistic Agents (opens in a new tab)

  11. The proton-coupled folate transporter: biology and therapeutic applications to cancer

    … ribonucleotide (GAR) formyltransferase (GARFTase) in the de novo purine biosynthesis pathway as the principle drug target. This was confirmed by in situ measurement of [14C]glycine incorporation into [14C]formylGAR in treated cells. Furthermore, contraction of intracellular purine …

    wayne-thes Repository record for The proton-coupled folate transporter: biology and therapeutic applications to cancer (opens in a new tab)

  12. Pyrrolo[2,3-d]pyrimidine Classical Antifolates for Targeted Cancer Chemotherapy- Applications of Bioisosteric and Regioisomeric Substitutions for Improved Tumor-Selectivity and Potency

    … (MTX; DHFR inhibitor), pemetrexed (PMX; TS and GARFTase inhibitor), pralatrexate (PTX; DHFR inhibitor), and raltitrexed (RTX; TS inhibitor), have two major disadvantages: (1) dose-limiting toxicities due to ubiquitous transport via the reduced folate carrier (RFC) and (2) drug-resistance; …

    duquesne Repository record for Pyrrolo[2,3-d]pyrimidine Classical Antifolates for Targeted Cancer Chemotherapy- Applications of Bioisosteric and Regioisomeric Substitutions for Improved Tumor-Selectivity and Potency (opens in a new tab)

  13. Synthesis of 2,4,6-Substituted Pyrrolo[2,3-d]pyrimidines as Potential Anticancer Agents

    <p>This thesis mainly focuses on the introduction of the background and work have been done in the areas of antifolates development, such as folate function, its three uptake mechanisms inside human cells, antifolates’ role in chemotherapy, <em>et. al</em>. In addition, the …

    duquesne Repository record for Synthesis of 2,4,6-Substituted Pyrrolo[2,3-d]pyrimidines as Potential Anticancer Agents (opens in a new tab)